{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T06:28:24Z","timestamp":1719469704135},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T00:00:00Z","timestamp":1336089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T00:00:00Z","timestamp":1336089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/cgt.2012.16","type":"journal-article","created":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T10:18:35Z","timestamp":1336126715000},"page":"451-459","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["MicroRNA silencing improves the tumor specificity of adenoviral transgene expression"],"prefix":"10.1038","volume":"19","author":[{"given":"P B","family":"Card","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R T","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R","family":"Gil del Alcazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R D","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,4]]},"reference":[{"key":"BFcgt201216_CR1","unstructured":"www.wiley.co.uk\/genmed\/clinical [Web Page], J Gene Med Gene Therapy Clinical Trials Worldwide, Accessed on 23 October 2010."},{"key":"BFcgt201216_CR2","first-page":"57","volume":"542","author":"R Alemany","year":"2009","unstructured":"Alemany R . Designing adenoviral vectors for tumor-specific targeting. Methods Mol Biol 2009; 542: 57\u201374.","journal-title":"Methods Mol Biol"},{"key":"BFcgt201216_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00041433-199604000-00010","volume":"7","author":"RD Gerard","year":"1996","unstructured":"Gerard RD, Chan L . Adenovirus-mediated gene transfer: strategies and applications in lipoprotein research. Curr Opin Lipidol 1996; 7: 105\u2013111.","journal-title":"Curr Opin Lipidol"},{"key":"BFcgt201216_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0008-6363(97)00134-X","volume":"35","author":"RD Gerard","year":"1997","unstructured":"Gerard RD, Collen D . Adenovirus gene therapy for hypercholesterolemia, thrombosis and restenosis. Cardiovasc Res 1997; 35: 451\u2013458.","journal-title":"Cardiovasc Res"},{"key":"BFcgt201216_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/cgt.2010.1","volume":"17","author":"RT Hogg","year":"2010","unstructured":"Hogg RT, Garcia JA, Gerard RD . Adenoviral targeting of gene expression to tumors. Cancer Gene Ther 2010; 17: 375\u2013386.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201216_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/cgt.2010.78","volume":"18","author":"RT Hogg","year":"2011","unstructured":"Hogg RT, Thorpe P, Gerard RD . Retargeting adenoviral vectors to improve gene transfer into tumors. Cancer Gene Ther 2011; 18: 275\u2013287.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201216_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.gt.3300802","volume":"6","author":"M Praus","year":"1999","unstructured":"Praus M, Wauterickx K, Collen D, Gerard RD . Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors. Gene Ther 1999; 6: 227\u2013236.","journal-title":"Gene Ther"},{"key":"BFcgt201216_CR8","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1089\/10430340050032429","volume":"11","author":"O Varenne","year":"2000","unstructured":"Varenne O, Sinnaeve P, Gillijns H, Iung B, Laurysens V, Meurrens K et al. Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries. Hum Gene Ther 2000; 11: 1329\u20131339.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201216_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.gt.3302036","volume":"10","author":"Q Liu","year":"2003","unstructured":"Liu Q, Muruve DA . Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 2003; 10: 935\u2013940.","journal-title":"Gene Ther"},{"key":"BFcgt201216_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/10430349950018364","volume":"10","author":"DA Muruve","year":"1999","unstructured":"Muruve DA, Barnes MJ, Stillman IE, Libermann TA . Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther 1999; 10: 965\u2013976.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201216_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","volume":"8","author":"S Worgall","year":"1997","unstructured":"Worgall S, Wolff G, Falck-Pedersen E, Crystal RG . Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 1997; 8: 37\u201344.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201216_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843\u2013854.","journal-title":"Cell"},{"key":"BFcgt201216_CR13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM . Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704\u2013714.","journal-title":"Nat Rev Genet"},{"key":"BFcgt201216_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","volume":"79","author":"MR Fabian","year":"2010","unstructured":"Fabian MR, Sonenberg N, Filipowicz W . Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79: 351\u2013379.","journal-title":"Annu Rev Biochem"},{"key":"BFcgt201216_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4161\/rna.1.2.1066","volume":"1","author":"J Chang","year":"2004","unstructured":"Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 2004; 1: 106\u2013113.","journal-title":"RNA Biol"},{"key":"BFcgt201216_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","volume":"12","author":"M Lagos-Quintana","year":"2002","unstructured":"Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T . Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12: 735\u2013739.","journal-title":"Curr Biol"},{"key":"BFcgt201216_CR17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jhep.2008.01.019","volume":"48","author":"M Girard","year":"2008","unstructured":"Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A . miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 2008; 48: 648\u2013656.","journal-title":"J Hepatol"},{"key":"BFcgt201216_CR18","doi-asserted-by":"publisher","first-page":"11009","DOI":"10.1128\/JVI.01608-08","volume":"82","author":"E Ylosmaki","year":"2008","unstructured":"Ylosmaki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, Saksela K . Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA. J Virol 2008; 82: 11009\u201311015.","journal-title":"J Virol"},{"key":"BFcgt201216_CR19","doi-asserted-by":"publisher","first-page":"e1000440","DOI":"10.1371\/journal.ppat.1000440","volume":"5","author":"R Cawood","year":"2009","unstructured":"Cawood R, Chen HH, Carroll F, Bazan-Peregrino M, van Rooijen N, Seymour LW . Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog 2009; 5: e1000440.","journal-title":"PLoS Pathog"},{"key":"BFcgt201216_CR20","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1038\/mt.2008.159","volume":"16","author":"T Suzuki","year":"2008","unstructured":"Suzuki T, Sakurai F, Nakamura S, Kouyama E, Kawabata K, Kondoh M et al. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy. Mol Ther 2008; 16: 1719\u20131726.","journal-title":"Mol Ther"},{"key":"BFcgt201216_CR21","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1038\/mt.2009.225","volume":"17","author":"C Wu","year":"2009","unstructured":"Wu C, Lin J, Hong M, Choudhury Y, Balani P, Leung D et al. Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy. Mol Ther 2009; 17: 2058\u20132066.","journal-title":"Mol Ther"},{"key":"BFcgt201216_CR22","doi-asserted-by":"publisher","first-page":"e8916","DOI":"10.1371\/journal.pone.0008916","volume":"5","author":"J Leja","year":"2010","unstructured":"Leja J, Nilsson B, Yu D, Gustafson E, Akerstrom G, Oberg K et al. Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability. PLoS One 2010; 5: e8916.","journal-title":"PLoS One"},{"key":"BFcgt201216_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nrc1627","volume":"5","author":"D Neri","year":"2005","unstructured":"Neri D, Bicknell R . Tumour vascular targeting. Nat Rev Cancer 2005; 5: 436\u2013446.","journal-title":"Nat Rev Cancer"},{"key":"BFcgt201216_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.11.1.72","volume":"11","author":"H Tian","year":"1997","unstructured":"Tian H, McKnight SL, Russell DW . Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997; 11: 72\u201382.","journal-title":"Genes Dev"},{"key":"BFcgt201216_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0092-8674(81)90057-X","volume":"25","author":"SL McKnight","year":"1981","unstructured":"McKnight SL, Gavis ER, Kingsbury R, Axel R . Analysis of transcriptional regulatory signals of the HSV thymidine kinase gene: identification of an upstream control region. Cell 1981; 25: 385\u2013398.","journal-title":"Cell"},{"key":"BFcgt201216_CR26","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1167\/iovs.07-1469","volume":"49","author":"EM Dioum","year":"2008","unstructured":"Dioum EM, Clarke SL, Ding K, Repa JJ, Garcia JA . HIF-2alpha-haploinsufficient mice have blunted retinal neovascularization due to impaired expression of a proangiogenic gene battery. Invest Ophthalmol Vis Sci 2008; 49: 2714\u20132720.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFcgt201216_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/BF03402119","volume":"5","author":"K Aoki","year":"1999","unstructured":"Aoki K, Barker C, Danthinne X, Imperiale MJ, Nabel GJ . Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro. Mol Med 1999; 5: 224\u2013231.","journal-title":"Mol Med"},{"key":"BFcgt201216_CR28","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.1128\/JVI.02575-07","volume":"82","author":"J Chang","year":"2008","unstructured":"Chang J, Guo JT, Jiang D, Guo H, Taylor JM, Block TM . Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol 2008; 82: 8215\u20138223.","journal-title":"J Virol"},{"key":"BFcgt201216_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcb.20982","volume":"99","author":"H Kutay","year":"2006","unstructured":"Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006; 99: 671\u2013678.","journal-title":"J Cell Biochem"},{"key":"BFcgt201216_CR30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/jcb.22328","volume":"108","author":"AK Zaiss","year":"2009","unstructured":"Zaiss AK, Machado HB, Herschman HR . The influence of innate and pre-existing immunity on adenovirus therapy. J Cell Biochem 2009; 108: 778\u2013790.","journal-title":"J Cell Biochem"},{"key":"BFcgt201216_CR31","doi-asserted-by":"publisher","first-page":"e16152","DOI":"10.1371\/journal.pone.0016152","volume":"6","author":"R Cawood","year":"2011","unstructured":"Cawood R, Wong SL, Di Y, Baban DF, Seymour LW . MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity. PLoS One 2011; 6: e16152.","journal-title":"PLoS One"},{"key":"BFcgt201216_CR32","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1128\/JVI.78.9.4498-4507.2004","volume":"78","author":"IB DeMeritt","year":"2004","unstructured":"DeMeritt IB, Milford LE, Yurochko AD . Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol 2004; 78: 4498\u20134507.","journal-title":"J Virol"},{"key":"BFcgt201216_CR33","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1038\/sj.onc.1209943","volume":"25","author":"MS Hayden","year":"2006","unstructured":"Hayden MS, West AP, Ghosh S . NF-kappaB and the immune response. Oncogene 2006; 25: 6758\u20136780.","journal-title":"Oncogene"},{"key":"BFcgt201216_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/mthe.2000.0227","volume":"3","author":"N Tao","year":"2001","unstructured":"Tao N, Gao GP, Parr M, Johnston J, Baradet T, Wilson JM et al. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol Ther 2001; 3: 28\u201335.","journal-title":"Mol Ther"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201216","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:38:38Z","timestamp":1647952718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,4]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFcgt201216"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2012.16","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,4]]},"assertion":[{"value":"28 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}